[1]
Л. М. Шеремета, “ABOUT ADVERSE REACTIONS AND VALUE CRITERIA ‘BENEFIT / RISK’ WHEN USING DRUGS THAT AFFECT THE NERVOUS SYSTEM (according to reports, registered in Ivano-Frankivsk region during 2007-2012)”, pulse, no. 4(20), pp. 100–105, Sep. 2019.